Spinal implant inventor sues over four ‘infringed’ products
RSB Spine files patent infringement lawsuit against competitors over spinal implant products | Plaintiff claims the defendants had knowledge of patent infringement.
Womble Bond Dickinson hires patent team
Biopharmaceutical patent partner leads team of technical advisors and an associate in California | Partner experienced in patent prosecution, freedom-to-operate analysis, and assessing infringement validity in the pharma and biotech industry.
Novartis asks court for access to rival’s documents over trade secrets claims
Swiss multinational says competitor has been “uncooperative” in investigation into whether former Novartis employee took trade secrets |Novartis files complaint for discovery, asking for permission to issue subpoena.
ITC investigates online pharmacies after Eli Lilly complaint
International Trade Commission is to investigate 11 online pharmacies after Eli Lilly files trademark infringement complaint | The company accuses pharmacies of selling “low-grade” versions of its Mounjaro diabetes medicine.
Fed Circ contests PTAB over single or plural meaning in microfluidic device patent
Judges partially overturn decision that ABS had failed to prove claims in Cytonome patent were invalid | PTAB and appeals court differ in interpretation of whether claims language had single or plural meaning.
Foley Hoag completes IP team hire
Amy Baker Mandragouras’ (pictured) team follow her from Cooley | New counsel’s scientific expertise is “second-to-none” | Team has experience in strategic counselling and biotech patent portfolios.
EU court confirms €60m fine for Teva
Luxemboug court agrees with European Commission that ‘beneficial arrangement’ between Teva and Cephalon delayed generic market entry of sleep disorder drug | Teva and subsidiary Cephalon to pay around €30m each plus costs.
Hogan Lovells hires Hatch-Waxman litigators
The firm's newest life sciences partners are patent litigators in biotech and pharma fields | Duo have secured Hatch-Waxman litigation victories.
Arthrex wins at PTAB over joint repair patents
Medical device company prevails after requesting inter partes reviews of three related patents | Patent Trial and Appeal Board finds obviousness in patents describing joint tissue repair and stabilisation.
US biotech claims rival poached key employees to speed up delayed drug programme
Rocket Pharma says Lexeo Therapeutics hired its staff to keep clinical trial programme on track | Employees transferred confidential and proprietary information before leaving the company, it claims.
